Healthtech Startups

A clinical-stage biopharmaceutical company developing investigational therapies for patients with liver and cardiometabolic diseases, with a lead candidate (pegozafermin) being evaluated for metabolic dysfunction-associated steatohepatitis and severe hypertriglyceridemia.

3 investors

A-SEEDS is a Shinshu University spin-out developing non-viral gene-modified immune cell therapies, including non-viral CAR-T cell products, to treat pediatric and young-adult cancers, including solid tumors, that lack effective treatments. The company focuses on advancing basic research through non-clinical development into clinical application of these cancer cell therapies.

3 investors

A-wave develops medical devices and related software/hardware products for healthcare applications. The company was founded by healthcare professionals with Stanford Biodesign training and conducts research in medical device innovation.

3 investors

Abacus Insights provides a unified data infrastructure platform that standardizes healthcare data across silos, enabling analytics and cost reduction for healthcare organizations.

3 investors

Abby Care provides specialized training, ongoing support, and community resources for caregivers across the U.S., focusing on easing the challenges families face when navigating care.

3 investors

AbClon is a biotech company developing new therapeutics, including advanced gene and cell therapies and antibody-based treatments. Its work centers on CAR-T cell therapy and antibody discovery platforms for human disease.

3 investors

3 investors

AbilityPharma develops innovative oncology therapies that induce autophagy to treat various cancers and address unmet medical needs. The company has advanced therapies including ibrilatazar (ABTL0812) through clinical trials for lung cancer, pancreatic cancer, and other tumor types.

3 investors

ABK Biomedical is a clinical-stage medical device company that develops x-ray visible glass microspheres for Y-90 radioembolization and embolic treatment of cancers such as liver cancer. Spun out of Dalhousie University, it serves interventional oncology and radiology applications.

3 investors

Able Innovations builds the ALTA Platform, a device that lets a single caregiver transfer patients at the push of a button to reduce physical strain and protect patient skin and tissue. The product targets healthcare providers and their patient-handling workflows.

3 investors

AbolerIS Pharma develops therapeutic approaches that regulate the immune system by inducing immune tolerance while preserving useful immune responses, targeting inflammatory, autoimmune, and degenerative diseases. It is a biotech company working on drug candidates based on regulatory T cell research.

3 investors

Abra Dental is a family dental practice offering services ranging from cleanings and fillings to braces, implants, and veneers for children and families. It operates as an inclusive practice with multilingual staff serving patients in English, Spanish, and Portuguese.

3 investors

Abzena is an integrated CDMO and CRO providing end-to-end development and cGMP manufacturing services for complex biologics and bioconjugates, including ADCs, AOCs, bispecifics, and HPAPIs. It serves biotech, academic, and pharmaceutical customers across the drug development lifecycle from discovery through commercial manufacturing.

3 investors

Acarix provides diagnostic systems and supports investigator-initiated clinical trials and research projects to advance medical knowledge in cardiovascular disease assessment.

3 investors

Bethesda-based provider of in-home and virtual primary, behavioral and social care for low-income patients with complex needs.

3 investors

Accupac is a contract development and manufacturing partner that formulates and manufactures beauty, personal care, and healthcare products for global consumer brands and emerging indie brands. The company serves CPGs and indie brands across cosmetics, skincare, haircare, pharmaceuticals, and medical devices.

3 investors

Accure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases. It operates in the biotech sector.

3 investors

Achieve is a specialty pharmaceutical company developing and commercializing cytisinicline as a treatment for nicotine dependence, aimed at helping people who smoke quit. It targets the global smoking health problem through this drug candidate.

3 investors

Achillion conducts research and development focused on addressing rare disease challenges through investigation of new therapeutic targets, modalities, and technologies. The company serves rare disease patients and their families globally.

3 investors

Tango Belt develops a wearable device that detects serious hip-impacting falls in older adults using fall-risk detection methodology. The product targets elderly populations to improve safety in everyday life.

3 investors

Actual Signal develops a smartphone-based platform that enables continuous monitoring of patients with neurological conditions, particularly Parkinson's disease, by capturing real-world data to help clinicians detect early changes and personalize treatments. The platform transforms traditional clinic visits into ongoing, data-driven patient care for healthcare organizations and care teams.

3 investors

Actus Nutrition manufactures and supplies protein, fat, and functional nutritional ingredients derived from milk and whey for food and beverage manufacturers. The company serves the food industry with branded ingredient solutions including casein proteins, whey proteins, and specialty dairy components.

3 investors

3 investors

Ada offers intelligent health technology, including a medical library of doctor-created, research-based information about conditions and symptoms to help people make informed health decisions. It aims to support better health outcomes and clinical excellence for consumers.

3 investors